IRIS
MARRELLI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.478
EU - Europa 23.213
AS - Asia 12.988
SA - Sud America 2.156
AF - Africa 755
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 21
Totale 68.659
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.066
GB - Regno Unito 5.240
RU - Federazione Russa 4.719
CN - Cina 4.518
SG - Singapore 3.978
IE - Irlanda 3.043
IT - Italia 2.709
BR - Brasile 1.798
UA - Ucraina 1.762
SE - Svezia 1.518
FR - Francia 1.426
VN - Vietnam 1.322
DE - Germania 1.255
HK - Hong Kong 1.066
FI - Finlandia 666
KR - Corea 581
IN - India 336
ZA - Sudafrica 313
BD - Bangladesh 254
CA - Canada 203
ES - Italia 186
AR - Argentina 139
IQ - Iraq 119
NG - Nigeria 119
NL - Olanda 119
TR - Turchia 118
MX - Messico 117
PL - Polonia 96
BE - Belgio 93
JP - Giappone 92
ID - Indonesia 79
CI - Costa d'Avorio 75
PK - Pakistan 59
IR - Iran 53
SA - Arabia Saudita 53
AT - Austria 52
EG - Egitto 49
LT - Lituania 43
RO - Romania 43
EC - Ecuador 42
JO - Giordania 42
KE - Kenya 41
VE - Venezuela 40
MA - Marocco 39
AU - Australia 38
UZ - Uzbekistan 35
PH - Filippine 33
PT - Portogallo 32
CL - Cile 31
PY - Paraguay 31
CZ - Repubblica Ceca 30
NP - Nepal 29
AE - Emirati Arabi Uniti 28
MU - Mauritius 27
TN - Tunisia 26
AZ - Azerbaigian 25
CO - Colombia 25
MY - Malesia 24
CH - Svizzera 23
KG - Kirghizistan 23
PE - Perù 21
DZ - Algeria 19
UY - Uruguay 19
IL - Israele 18
KZ - Kazakistan 18
GR - Grecia 17
ET - Etiopia 16
EU - Europa 16
JM - Giamaica 15
AL - Albania 14
SI - Slovenia 14
BG - Bulgaria 12
LV - Lettonia 12
TH - Thailandia 12
CR - Costa Rica 11
PA - Panama 11
SN - Senegal 11
TW - Taiwan 11
EE - Estonia 10
HN - Honduras 10
MD - Moldavia 10
BO - Bolivia 9
DK - Danimarca 9
NZ - Nuova Zelanda 9
RS - Serbia 9
TT - Trinidad e Tobago 9
HU - Ungheria 8
DO - Repubblica Dominicana 7
NI - Nicaragua 7
NO - Norvegia 7
AO - Angola 6
BH - Bahrain 6
BY - Bielorussia 6
HR - Croazia 6
SV - El Salvador 6
SY - Repubblica araba siriana 6
AM - Armenia 5
CY - Cipro 5
GE - Georgia 5
LB - Libano 5
Totale 68.568
Salva come PNG Salva come JPEG
Città #
Southend 4.666
Dallas 4.017
Fairfield 3.121
Dublin 3.012
Ashburn 2.124
Singapore 2.099
Chandler 1.560
Jacksonville 1.520
Woodbridge 1.371
Moscow 1.321
Santa Clara 1.317
Wilmington 1.177
Seattle 1.133
San Jose 1.111
Houston 1.106
Beijing 1.035
Hong Kong 1.024
Cambridge 991
Ann Arbor 780
Hefei 642
Princeton 575
Seoul 562
Nanjing 479
The Dalles 455
Los Angeles 403
Ho Chi Minh City 396
Siena 386
New York 369
Council Bluffs 344
Munich 340
Lauterbourg 336
Hanoi 322
Milan 290
Johannesburg 278
Helsinki 270
San Mateo 227
Boardman 225
Shanghai 186
São Paulo 184
San Diego 169
Buffalo 165
Florence 160
Shenyang 146
Nanchang 141
Columbus 132
Orem 122
Málaga 117
Rome 114
Abuja 110
London 104
Redondo Beach 101
Tianjin 98
Frankfurt am Main 91
Dong Ket 89
Hebei 89
Brussels 85
Changsha 81
Düsseldorf 78
Turku 78
Abidjan 75
San Francisco 75
Tokyo 73
Warsaw 72
Kunming 68
Jiaxing 66
Da Nang 64
Chicago 63
Jinan 62
Montreal 62
Phoenix 60
Bengaluru 57
Guangzhou 56
Manchester 56
Rio de Janeiro 56
Toronto 56
Chennai 55
Brooklyn 52
Dearborn 50
Atlanta 48
Menlo Park 48
Denver 47
Ningbo 46
Norwalk 46
Stockholm 46
Venezia 46
Zhengzhou 45
Boston 43
Haiphong 42
Naples 42
Baghdad 40
Belo Horizonte 40
Lappeenranta 40
Washington 40
Bologna 38
Mexico City 38
Amman 37
Brasília 37
Poplar 35
Mumbai 34
Vienna 34
Totale 46.114
Salva come PNG Salva come JPEG
Nome #
Patologie del duodeno 629
612. Molecular background of high risk and low risk areas of gastric cancer in Italy 473
354. KRAS mutation in gastric cancer- molecular, and clinico-pathological characteristic 369
Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) 364
Gastric cancer maximum tumour diameter reduction rate at CT examination as a radiological index for predicting histopathological regression after neoadjuvant treatment: A multicentre GIRCG study 359
65. Molecular surgery for gastric cancer-role of microsatellite instability in elderly patients 344
613. Lymph node metastases in microsatellite unstable gastric cancer 337
530. Minimally invasive surgery for the treatment of colo-rectal adenocarcinoma: Laparoscopic and robotic approach 337
338. Comparing characteristics and survival outcomes of adolescent and young adults to mature patients with colorectal cancer 334
C-Met targeting in advanced gastric cancer: An open challenge 333
A clinical case of duodenal gastrointestinal stromal tumor with a peculiarity in the surgical approach. 323
A case of pancreatic somatostatinoma [Considerazioni su un caso di somatostatinoma a localizzazione pancreatica] 321
353. PIK3CA mutation in gastric cancer and the role of different codon mutations in the new molecular division of that neoplasm 320
611. Gastric cancer patients with familial aggregation of gastric cancer and Lynch syndrome associated cancers with microsatellite instability 316
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 311
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer 311
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 306
Clinical evaluation of the Mannheim Prognostic Index in post-operative peritonitis: a prospective cohort study 306
Accuracy of MDCT in the Preoperative Definition of Peritoneal Cancer Index (PCI) in Patients with Advanced Ovarian Cancer Who Underwent Peritonectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 303
610. Heterogeneity of new molecular gastric cancer classifications. Clinico-pathological characteristic 302
Breast cancer local recurrence: risk factors and prognostic relevance of early time to recurrence 295
A case of small-cell gastric carcinoma with an adenocarcinoma component and hepatic metastases: treatment with systemic and intra-hepatic chemotherapy 294
Age Related Co-Morbidities in Colorectal Cancer Patients: Surgical Problems and Prognostic Impact 294
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer 289
Familial aggregation of gastric cancer with microsatellite instability** 283
A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer 279
Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases 278
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 277
Complications after surgery for gastric cancer in patients aged 80 years and over 276
Molecular key to understand the gastric cancer biology in elderly patients—The role of microsatellite instability 275
High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability 273
Recurrence after surgery in esophago-gastric junction adenocarcinoma: Current management and future perspectives 272
Comparison between 7th and 8th edition of AJCC TNM staging system for gastric cancer: Old problems and new perspectives 272
Robotic versus laparoscopic gastrectomy for gastric cancer: protocol for umbrella review of systematic reviews and meta-analyses 272
CA 19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions 271
A new way to experience the International Gastric Cancer Association Congress: the Web Round Tables 270
A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. 269
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 264
Clinical impact of molecular classifications in gastric cancer 264
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 263
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer 262
Accuracy of MDCT in preoperative definition of maximum tumour diameter in patients with gastric cancer 262
Hyperthermic intrathoracic chemotherapy after extended pleurectomy and decortication for malignant pleura mesothelioma: An observational study on outcome and microcirculatory changes 262
A rare case of primary small bowel adenocarcinoma with intussusception. 261
KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status 261
Western Experience of Hepatolithiasis: Clinical Insights from a Case Series in a Tertiary Center 260
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. 260
Signet ring cell percentage in poorly cohesive gastric cancer patients: a potential novel predictor of survival 260
Re-evaluation of Mannheim prognostic index in perforative peritonitis: Prognostic role of advanced age. A prospective cohort study 259
A comprehensive PDX gastric cancer collection captures cancer cell–intrinsic transcriptional MSI traits 259
Antimicrobial prophylaxis reduces the rate of surgical site infection in upper gastrointestinal surgery: a systematic review 259
Is sleeve gastrectomy a therapeutic procedure for all obese patients? 257
Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer 256
Computed Tomographic Evaluation of Mesentery : Diagnostic Value in Acute Mesenteric Ischemia. 255
K-RAS mutation in gastric cancer and its link with microsatellite instability status 255
The pattern of lymph node metastases in microsatellite unstable gastric cancer 253
E-cadherin and hereditary diffuse gastric cancer. 251
CDH1 C-160A promoter polymorphism and gastric cancer risk 249
Is tissue inhibitor of metalloproteinase-1 a new prognosticator for breast cancer? An analysis of 266 cases 248
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 248
Accuracy of MDCT in preoperative definition of maximum tumor diameter in patients with gastric cancer 248
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 248
Evidence of tumor microsatellite instability in gastric cancer with familial aggregation 247
Clinical and oncological value of preoperative BMI in gastric cancer patients: A single center experience 246
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results 246
The percentage of signet ring cells is inversely related to aggressive behavior and poor prognosis in mixed-type gastric cancer 244
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study 244
Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer 242
Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an italian family 242
Carcinomi squamosi e adenosquamosi del colon-retto: descrizione di tre casi clinici e revisione della letteratura 240
Accuracy of MDCT in preoperative definition of maximum tumor diameter in patients with gastric cancer 240
Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer 240
Robotic single docking total colectomy for ulcerative colitis: First experience with a novel technique 238
Presacral ganglioneuroma: a case report and review of literature 237
Potential impact of molecular classification on tailored lymphadenectomy for gastric cancer 232
Approccio multimodale al trattamento delle metastasi epatiche. 230
High incidence of familial gastric cancer in Tuscany, a region in Italy. 230
Clinical Outcome of Primary and Postoperative Visceral Perforations 228
Treatment of the intraabdominal abscesses through percutaneous ultrasound-guided drainage in oncological patients: Clinical and microbiological data. 228
Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-Analysis 227
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer 227
Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study 227
Gastrointestinal stromal tumors (GIST): a proposal of a “CT-based predictive model of Miettinen index” in predicting the risk of malignancy 227
Factors influencing survival after hepatectomy for metastases from gastric cancer 226
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts 226
Il ruolo della chemioipertermia nel carcinoma del colon-retto 225
Super-extended (D3) lymphadenectomy in advanced gastric cancer. 224
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data 224
Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study 223
609. Pathology of signet-ring cell in gastric cancer and its prognostic value in surgical treatment 221
Elastofibroma dorsi: three cases of personal experience 221
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience 221
Different pathological features and prognosis in gastric cancer patients coming from high-risk and low-risk areas of Italy. 221
PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene 221
Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial 220
Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors. 217
An aggressive early gastric cancer: Kodama's PenA type 216
From digital world to real life: A robotic approach to the esophagogastric junction with a 3D printed model 216
Gastric linitis plastica: which role for surgical resection? 215
Cell kinetic patterns in early gastric cancer 214
Totale 26.874
Salva come PNG Salva come JPEG
Categoria #
all - tutte 211.055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 211.055
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021429 0 0 0 0 0 0 0 0 0 0 0 429
2021/20224.288 375 532 279 293 218 167 208 147 224 463 477 905
2022/20235.840 341 373 789 836 563 1.286 142 447 583 167 165 148
2023/20244.459 217 137 364 158 149 1.175 1.637 82 25 154 58 303
2024/20259.549 312 500 780 474 1.268 666 233 563 817 385 1.098 2.453
2025/202623.338 1.782 3.598 2.863 2.648 4.341 968 2.685 718 950 1.318 962 505
Totale 69.335